Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Liver Cancer treatment details. Chemotherapy. The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States

Survival: 10.7 months
Toxicity Grade: 3
Treatments: Chemotherapy
Country: United States
City/State/Province: Houston, TX
Hospital: The University of Texas M.D. Anderson Cancer Center
Journal: Link
Date: 9/2007

Patients: This phase II study involved 40 patients with advanced, unresectable hepatocellular carcinoma (liver cancer). The median age was 64 years, ranging from 33 to 83. The majority (80%) of patients were men.

Treatment: Patients were treated with the chemotherapy drug erlotinib.

Toxicity: No grade 4 toxicities were reported. The most common grade 3 toxicities were diarrhea, folliculitis, fatigue, pruritus (itching), dry skin, xerostomia (dry mouth), and epistaxis (bleeding from the nose).

Results: The median overall survival was 10.75 months (43 weeks).

Correspondence: Dr. Melanie Thomas

E-mail to a Friend Email Physician More Information